<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article-commentary" dtd-version="1.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="issn">1043-3155</journal-id>
<journal-id journal-id-type="nlm-ta">Pediatr Neurol Briefs</journal-id>
<journal-id journal-id-type="pmc">pedneurbriefs</journal-id>
<journal-id journal-id-type="iso-abbrev">Pediatr Neurol Briefs</journal-id>
<journal-title-group>
<journal-title>Pediatric Neurology Briefs</journal-title>
<abbrev-journal-title>Pediatr Neurol Briefs</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2166-6482</issn>
<issn pub-type="ppub">1043-3155</issn>
<issn-l>2166-3155</issn-l>
<publisher>
<publisher-name>Pediatric Neurology Briefs Publishers</publisher-name>
<publisher-loc>Chicago, IL, USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PNB-6-50-b</article-id>
<article-id pub-id-type="doi">10.15844/pedneurbriefs-6-7-3</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Seizure Disorders</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v2">
<subject>Neurology</subject>
<subject>Pediatrics</subject>
<subject>Nervous System Diseases</subject>
<subject>Child Development</subject>
<subject>Brain Diseases</subject>
<subject>Neurosurgery</subject>
<subject>Child</subject>
<subject>Infant</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Recurrent Status Epilepticus</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0173-7931</contrib-id>
<name>
<surname>Millichap</surname>
<given-names>J. Gordon</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="AF0001">1</xref>
<xref ref-type="aff" rid="AF0002">2</xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
</contrib>
</contrib-group>
<aff id="AF0001">
<label>1</label>Division of Neurology, Children&#x0027;s Memorial Hospital, Chicago, IL</aff>
<aff id="AF0002">
<label>2</label>Departments of Pediatrics and Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL</aff>
<author-notes>
<corresp id="cor1"><label>&#x002A;</label>Correspondence: Dr. J. Gordon Millichap, E-mail: <email xlink:href="jgmillichap@northwestern.edu">jgmillichap@northwestern.edu</email>
</corresp>
</author-notes>
<pub-date date-type="pub" publication-format="print">
<month>07</month>
<year>1992</year>
</pub-date>
<pub-date date-type="pub" publication-format="electronic">
<day>01</day>
<month>07</month>
<year>2016</year>
</pub-date>
<volume>6</volume>
<issue>7</issue>
<fpage>50</fpage>
<lpage>51</lpage>
<permissions>
<copyright-statement>Copyright: &#x00A9; 1992 The Author(s)</copyright-statement>
<copyright-year>1992</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This work is licensed under the <uri xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International License</uri>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<related-article id="R1" related-article-type="commentary-article" ext-link-type="doi" xlink:href="10.1002/ana.410310606" vol="31" page="598">
<article-title>Recurrent status epilepticus in children</article-title>
</related-article>
<abstract abstract-type="web-summary" specific-use="electronic-only">
<p>The risk of recurrent status epilepticus in 95 children followed prospectively for a mean of 29 months was determined at the Montefiore Medical Center and affiliated hospitals of Albert Einstein College of Medicine, Bronx, New York.</p>
</abstract>
<kwd-group>
<kwd>Recurrent Status Epilepticus</kwd>
<kwd>Morbidity</kwd>
<kwd>Focal Motor Seizures</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>The risk of recurrent status epilepticus in 95 children followed prospectively for a mean of 29 months was determined at the Montefiore Medical Center and affiliated hospitals of Albert Einstein College of Medicine, Bronx, New York. Ages ranged from 1 month to 18 years (mean 4 years). The cause was idiopathic in 24, remote symptomatic in 18, febrile in 29, acute asymptomatic in 18 or a progressive neurologic disorder in 6. Neurologically abnormal children (34% of the study population) accounted for 88% of the recurrent status group and for all 5 children with multiple episodes of status epilepticus. The risk was related to the severity of the neurological abnormality, the multiply handicapped children being at highest risk. Fifteen of 16 children with recurrent status epilepticus were being treated with anti-epileptic drugs at the time of recurrence. The morbidity and mortality of status epilepticus were low. [<xref ref-type="bibr" rid="CIT0001">1</xref>]</p>
<disp-quote>
<p><bold>COMMENT.</bold> The authors indicate that status epilepticus in neurologically normal children is by and large an isolated event that should not unduly influence decisions regarding further therapy. The high risk subgroup of neurologically abnormal children with recurrent status epilepticus underscored the need for better treatment strategies.</p>
<p>The more frequent use of neurosurgical treatment of refractory status epilepticus is suggested by Gorman DG et al. in a report from the UCLA Pediatric Epilepsy Research Program, Los Angeles, CA [<xref ref-type="bibr" rid="CIT0002">2</xref>]. The resection of a right frontal focus in a 9 year old boy with left focal motor seizures and status epilepticus was followed by immediate control of the seizures and no seizures for more than 1 year post-operatively while using carbamazepine monotherapy.</p>
</disp-quote>
</body>
<back>
<ref-list>
<ref id="CIT0001">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shinnar</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Maytal</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Krasnoff</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Moshe</surname>
<given-names>SL</given-names>
</name>
</person-group>
<article-title>Recurrent status epilepticus in children</article-title>
<source>Ann Neurol</source>
<year>1992</year>
<month>Jun</month>
<volume>31</volume>
<issue>6</issue>
<fpage>598</fpage>
<lpage>604</lpage>
<pub-id pub-id-type="doi">10.1002/ana.410310606</pub-id>
<pub-id pub-id-type="pmid">1514772</pub-id>
</element-citation>
</ref>
<ref id="CIT0002">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gorman</surname>
<given-names>DG</given-names>
</name>
<name>
<surname>Shields</surname>
<given-names>WD</given-names>
</name>
<name>
<surname>Shewmon</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Chugani</surname>
<given-names>HT</given-names>
</name>
<name>
<surname>Finkel</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Comair</surname>
<given-names>YG</given-names>
</name>
</person-group>
<article-title>Neurosurgical treatment of refractory status epilepticus</article-title>
<source>Epilepsia</source>
<year>1992</year>
<month>May-Jun</month>
<volume>33</volume>
<issue>3</issue>
<fpage>546</fpage>
<lpage>549</lpage>
<pub-id pub-id-type="doi">10.1111/j.1528-1157.1992.tb01707.x</pub-id>
<pub-id pub-id-type="pmid">1592035</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>